| pubmed-article:16169219 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16169219 | lifeskim:mentions | umls-concept:C0917785 | lld:lifeskim |
| pubmed-article:16169219 | lifeskim:mentions | umls-concept:C1955846 | lld:lifeskim |
| pubmed-article:16169219 | lifeskim:mentions | umls-concept:C0456387 | lld:lifeskim |
| pubmed-article:16169219 | lifeskim:mentions | umls-concept:C0243077 | lld:lifeskim |
| pubmed-article:16169219 | lifeskim:mentions | umls-concept:C1707959 | lld:lifeskim |
| pubmed-article:16169219 | pubmed:issue | 22 | lld:pubmed |
| pubmed-article:16169219 | pubmed:dateCreated | 2005-10-5 | lld:pubmed |
| pubmed-article:16169219 | pubmed:abstractText | The semi-synthesis, in vitro and in vivo biological evaluation of corosolic acid (1) and maslinic acid (2) are described. Compounds 1 and 2 represent a new class of inhibitors of glycogen phosphorylases. Both 1 and 2 inhibit the increase of fasted plasma glucose of diabetic mice induced by adrenaline. It is therefore proposed that naturally occurring pentacyclic triterpenes 1 and 2 might reduce blood glucose, at least in part, through inhibiting hepatic glycogen degradation. | lld:pubmed |
| pubmed-article:16169219 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16169219 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16169219 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16169219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16169219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16169219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16169219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16169219 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16169219 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:16169219 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:16169219 | pubmed:author | pubmed-author:LowM BMB | lld:pubmed |
| pubmed-article:16169219 | pubmed:author | pubmed-author:WuXiaomingX | lld:pubmed |
| pubmed-article:16169219 | pubmed:author | pubmed-author:ZhangLuyongL | lld:pubmed |
| pubmed-article:16169219 | pubmed:author | pubmed-author:WenXiaoanX | lld:pubmed |
| pubmed-article:16169219 | pubmed:author | pubmed-author:SunHongbinH | lld:pubmed |
| pubmed-article:16169219 | pubmed:author | pubmed-author:WuGuanzhongG | lld:pubmed |
| pubmed-article:16169219 | pubmed:author | pubmed-author:NiPeizhouP | lld:pubmed |
| pubmed-article:16169219 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16169219 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:16169219 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:16169219 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16169219 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16169219 | pubmed:pagination | 4944-8 | lld:pubmed |
| pubmed-article:16169219 | pubmed:meshHeading | pubmed-meshheading:16169219... | lld:pubmed |
| pubmed-article:16169219 | pubmed:meshHeading | pubmed-meshheading:16169219... | lld:pubmed |
| pubmed-article:16169219 | pubmed:meshHeading | pubmed-meshheading:16169219... | lld:pubmed |
| pubmed-article:16169219 | pubmed:meshHeading | pubmed-meshheading:16169219... | lld:pubmed |
| pubmed-article:16169219 | pubmed:meshHeading | pubmed-meshheading:16169219... | lld:pubmed |
| pubmed-article:16169219 | pubmed:meshHeading | pubmed-meshheading:16169219... | lld:pubmed |
| pubmed-article:16169219 | pubmed:meshHeading | pubmed-meshheading:16169219... | lld:pubmed |
| pubmed-article:16169219 | pubmed:meshHeading | pubmed-meshheading:16169219... | lld:pubmed |
| pubmed-article:16169219 | pubmed:meshHeading | pubmed-meshheading:16169219... | lld:pubmed |
| pubmed-article:16169219 | pubmed:meshHeading | pubmed-meshheading:16169219... | lld:pubmed |
| pubmed-article:16169219 | pubmed:meshHeading | pubmed-meshheading:16169219... | lld:pubmed |
| pubmed-article:16169219 | pubmed:meshHeading | pubmed-meshheading:16169219... | lld:pubmed |
| pubmed-article:16169219 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16169219 | pubmed:articleTitle | Pentacyclic triterpenes. Part 1: the first examples of naturally occurring pentacyclic triterpenes as a new class of inhibitors of glycogen phosphorylases. | lld:pubmed |
| pubmed-article:16169219 | pubmed:affiliation | Department of Medicinal Chemistry, College of Pharmacy, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China. | lld:pubmed |
| pubmed-article:16169219 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:16169219 | lld:chembl |
